TY - JOUR
T1 - Sex differences and sex steroids in lung health and disease
AU - Townsend, Elizabeth A.
AU - Miller, Virginia M.
AU - Prakash, Y. S.
PY - 2012/2/1
Y1 - 2012/2/1
N2 - Sex differences in the biology of different organ systemsandthe influence of sexhormonesin modulating health and disease are increasingly relevant in clinical and research areas. Althoughworkhas focusedonsex differences and sex hormones in cardiovascular, musculoskeletal, and neuronal systems, there is now increasing clinical evidence for sex differences in incidence, morbidity, and mortality of lung diseases including allergic diseases (such as asthma), chronic obstructive pulmonary disease, pulmonary fibrosis, lung cancer, as well as pulmonary hypertension.Whethersuch differences are inherent and/or whether sex steroids play a role in modulating these differences is currently under investigation. The purpose of this review is to define sex differences in lung structure/function under normal and specific disease states, with exploration of whether and how sex hormone signaling mechanisms may explain these clinical observations. Focusing on adult age groups, the review addresses the following: 1) inherent sex differences in lung anatomy and physiology; 2) the importance of certain time points in life such as puberty, pregnancy, menopause, and aging; 3) expression and signaling of sex steroid receptors under normal vs. disease states; 4) potential interplay between different sex steroids; 5) the question of whether sex steroids are beneficial or detrimental to the lung; and 6) the potential use of sex steroid signaling as biomarkers and therapeutic avenues in lung diseases. The importance of focusing on sex differences and sex steroids in the lung lies in the increasing incidence of lung diseases in women and the need to address lung diseases across the life span.
AB - Sex differences in the biology of different organ systemsandthe influence of sexhormonesin modulating health and disease are increasingly relevant in clinical and research areas. Althoughworkhas focusedonsex differences and sex hormones in cardiovascular, musculoskeletal, and neuronal systems, there is now increasing clinical evidence for sex differences in incidence, morbidity, and mortality of lung diseases including allergic diseases (such as asthma), chronic obstructive pulmonary disease, pulmonary fibrosis, lung cancer, as well as pulmonary hypertension.Whethersuch differences are inherent and/or whether sex steroids play a role in modulating these differences is currently under investigation. The purpose of this review is to define sex differences in lung structure/function under normal and specific disease states, with exploration of whether and how sex hormone signaling mechanisms may explain these clinical observations. Focusing on adult age groups, the review addresses the following: 1) inherent sex differences in lung anatomy and physiology; 2) the importance of certain time points in life such as puberty, pregnancy, menopause, and aging; 3) expression and signaling of sex steroid receptors under normal vs. disease states; 4) potential interplay between different sex steroids; 5) the question of whether sex steroids are beneficial or detrimental to the lung; and 6) the potential use of sex steroid signaling as biomarkers and therapeutic avenues in lung diseases. The importance of focusing on sex differences and sex steroids in the lung lies in the increasing incidence of lung diseases in women and the need to address lung diseases across the life span.
UR - http://www.scopus.com/inward/record.url?scp=84857888066&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857888066&partnerID=8YFLogxK
U2 - 10.1210/er.2010-0031
DO - 10.1210/er.2010-0031
M3 - Review article
C2 - 22240244
AN - SCOPUS:84857888066
SN - 0163-769X
VL - 33
SP - 1
EP - 47
JO - Endocrine reviews
JF - Endocrine reviews
IS - 1
ER -